ProShare Advisors LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$221,894
-56.1%
10,782
+0.4%
0.00%0.0%
Q2 2023$505,135
+17.2%
10,743
+4.6%
0.00%0.0%
Q1 2023$430,971
-2.8%
10,271
-11.6%
0.00%
-50.0%
Q4 2022$443,339
+5.6%
11,624
+8.2%
0.00%0.0%
Q3 2022$420,000
+24.3%
10,742
+2.8%
0.00%
+100.0%
Q2 2022$338,000
+67.3%
10,450
+71.0%
0.00%
Q1 2022$202,000
-42.8%
6,111
-26.3%
0.00%
-100.0%
Q4 2021$353,000
-36.6%
8,295
-34.0%
0.00%
-50.0%
Q3 2021$557,000
-6.7%
12,565
+19.6%
0.00%0.0%
Q2 2021$597,000
-1.3%
10,507
+30.1%
0.00%0.0%
Q1 2021$605,000
-12.9%
8,078
+0.6%
0.00%
-33.3%
Q4 2020$695,000
+36.0%
8,031
-3.9%
0.00%
+50.0%
Q3 2020$511,000
+34.5%
8,359
-8.5%
0.00%0.0%
Q2 2020$380,000
+63.8%
9,134
+13.0%
0.00%0.0%
Q1 2020$232,000
-74.2%
8,083
-35.0%
0.00%
-50.0%
Q4 2019$898,000
-57.9%
12,444
-18.1%
0.00%
-66.7%
Q3 2019$2,132,000
-28.0%
15,198
-6.0%
0.01%
-33.3%
Q2 2019$2,961,000
-3.6%
16,170
-16.3%
0.02%0.0%
Q1 2019$3,073,000
+85.8%
19,321
+11.9%
0.02%
+50.0%
Q4 2018$1,654,000
-43.4%
17,272
-16.5%
0.01%
-40.0%
Q3 2018$2,921,000
-4.5%
20,679
+5.8%
0.02%
-4.8%
Q2 2018$3,060,000
-28.4%
19,548
-26.4%
0.02%
-25.0%
Q1 2018$4,276,000
-7.4%
26,549
-5.3%
0.03%
-12.5%
Q4 2017$4,618,000
+215.9%
28,036
+19.5%
0.03%
+146.2%
Q3 2017$1,462,000
-17.4%
23,465
+5.6%
0.01%
-27.8%
Q2 2017$1,770,000
+6.6%
22,222
-4.9%
0.02%
+5.9%
Q1 2017$1,660,000
+10.6%
23,362
-20.5%
0.02%0.0%
Q4 2016$1,501,000
+39.9%
29,396
+26.2%
0.02%
+13.3%
Q3 2016$1,073,000
+31.3%
23,291
-14.1%
0.02%
+36.4%
Q2 2016$817,000
-0.5%
27,110
+5.9%
0.01%0.0%
Q1 2016$821,000
-44.1%
25,610
+1.6%
0.01%
-38.9%
Q4 2015$1,470,000
+49.1%
25,219
+8.2%
0.02%
+28.6%
Q3 2015$986,000
-44.6%
23,300
-4.5%
0.01%
-44.0%
Q2 2015$1,781,000
+62.9%
24,404
+12.2%
0.02%
+92.3%
Q1 2015$1,093,000
+63.1%
21,756
+18.8%
0.01%
+62.5%
Q4 2014$670,00018,3120.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders